Medical Robots Market Report 2026

The medical robots market size has grown exponentially in recent years. It will grow from $18.83 billion in 2025 to $22.83 billion in 2026 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to hospital staff shortages, demand for automation in healthcare, growth of complex surgeries, infection control needs, workflow optimization.

The medical robots market size is expected to see exponential growth in the next few years. It will grow to $48.93 billion in 2030 at a compound annual growth rate (CAGR) of 21%. The growth in the forecast period can be attributed to AI-enabled care delivery, aging population healthcare demand, smart hospital investments, robotics-as-a-service models, digital health integration. Major trends in the forecast period include growth of hospital service robots, adoption of robotic pharmacy systems, expansion of telepresence robots, increased use in clinical workflow automation, demand for patient safety solutions.

The shortage of skilled surgeons is expected to drive the growth of the medical robots market going forward. Surgeons are highly trained medical professionals who perform invasive procedures to treat, repair, or remove damaged or diseased tissues within the human body using precise surgical techniques and instruments. Medical robots are increasingly used in hospitals to support surgeons by performing precise, minimally invasive procedures that enhance surgical accuracy and shorten patient recovery times. For example, in March 2023, the American Hospital Association, a US-based national organization, projected that the United States could face a shortage of up to 124,000 physicians by 2033 and would need to hire 200,000 nurses annually to meet rising healthcare demands. Therefore, the shortage of skilled surgeons is contributing to the growth of the medical robots market.

Major companies operating in the medical robots market are prioritizing the development of innovative solutions, such as artificial-intelligence-enabled endovascular robotic systems, to address the increasing need for high-precision and minimally invasive vascular procedures. For instance, in March 2025, WeMed Medical, a China-based healthcare robotics company, introduced ETcath, an advanced AI-enabled endovascular robotic system designed for stent placement, catheter navigation, and other vascular interventions. ETcath combines robotic manipulation, real-time imaging guidance, and AI-driven eye-hand-brain coordination to enhance surgical accuracy compared with manual catheter-based methods. The system delivers precise control of catheters and stents, improves navigation through complex vascular structures, and reduces surgeons’ exposure to radiation. Its intelligent imaging-guided interface supports safer, more consistent, and highly controlled minimally invasive procedures across cardiology and vascular surgery.

In October 2025, Zimmer Biomet Holdings, Inc., a U.S.-based musculoskeletal healthcare solutions company, acquired Monogram Technologies, Inc. for an undisclosed amount. With this acquisition, Zimmer Biomet aims to strengthen its robotics and artificial intelligence-assisted surgical capabilities, particularly in orthopedic procedures, by integrating Monogram's semi-autonomous, CT-based total knee arthroplasty robotic system and its fully autonomous surgical robotics platform. This integration is expected to enhance precision and efficiency in joint replacement surgeries. Monogram Technologies is a U.S.-based medical technology company specializing in semi- and fully autonomous robotic systems for orthopedic surgery.

Major companies operating in the medical robots market are Intuitive Surgical Inc, Mazor Robotics Ltd, Aethon, Ekso Bionics Holdings Inc, ReWalk Robotics, Medrobotics Corporation, Hocoma AG, Cyberdyne Inc., BD Rowa, Stryker Corporation, Medtronic plc, Zimmer Biomet Holdings Inc., Johnson & Johnson Services Inc., Hansen Medical Inc., Corindus Vascular Robotics Inc., CMR Surgical Ltd., Procept BioRobotics Corporation, TransEnterix Surgical Inc., Auris Health Inc., Titan Medical Inc., Accuray Incorporated, Synaptive Medical Inc., Omnicell Inc., Varian Medical Systems Inc., Elekta AB.

North America was the largest region in the medical robots market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical robots market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical robots market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical robots market consists of sales of radiotherapy machine robots, laboratory robots, robotic prosthetics, and social robots. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.